Oncotype DX cost effectivity to a Brazilian public hospital

被引：0
|
作者：
Cabello, C. [1 ]
de Andrade, R. N. [1 ]
Cabello, T. F. [1 ]
Teixeira, S. [1 ]
da Costa, L. S. [1 ]
Ramalho, S. [1 ]
机构：
[1] State Univ Campinas UNICAMP, Campinas, SP, Brazil
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P5-15-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-15-04
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Oncotype Dx in Men with Invasive Breast Cancer
    Duckworth, Lauren
    Hoda, Raza
    Komforti, Miglena
    Lewis, Gloria
    Cui, Xiaoyan
    Silbiger, Daniel
    Rowe, J. Jordi
    Downs-Kelly, Erinn
    McIntire, Patrick
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 111 - 112
  • [42] Evolving role of Oncotype DX® following TailoRx
    Gupta, Anjuli
    Greenup, Rachel
    Williamson, Hannah
    Thomas, Samantha
    Hwang, Shelley
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : 252 - 253
  • [43] Genomic signature in breast cancer: Oncotype DX®
    Teig, Benjamin
    ANNALES DE PATHOLOGIE, 2013, 33 (03) : 225 - 228
  • [44] Using Magee equations to predict Oncotype DX recurrence scores: A potential cost and time saying strategy?
    Al-Baimani, Khalid Salim
    Petkiewicz, Stephanie
    Song, Xinni
    Pond, Gregory Russell
    Clemons, Mark J.
    Robertson, Susan
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [45] Ki67 as a Predictor of Oncotype DX Recurrence Score and Its Impact on Health Care Cost
    Bittenbinder, R.
    Gallaty, A. M.
    Williams, C.
    Ochoa, D.
    Korourian, S.
    Henry-Tillman, R.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S72 - S72
  • [46] A comparison of tumor biology based on genomic health Oncotype DX recurrence scores in a private cancer center versus a public safety-net hospital
    Wecsler, Julie
    Karim, Roksana
    Ma, Yanling
    Nelson, Maria
    Sener, Stephen
    Russell, Christy
    Spicer, Darcy
    Lu, Janice
    Lang, Julie
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : 179 - 180
  • [47] Long-term cost-effectiveness of Oncotype DX® versus current clinical practice from a Dutch cost perspective
    Kip, Michelle
    Monteban, Helma
    Steuten, Lotte
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2015, 4 (05) : 433 - 445
  • [48] Cost-Effectiveness Evaluation of the Oncotype DX® Breast Cancer Assay in Clinical Practice in the UK.
    Holt, S. D. H.
    Bennett, H.
    Bertelli, G.
    Valentine, W. J.
    Phillips, C. J.
    CANCER RESEARCH, 2011, 71
  • [49] Relationship of histologic grade and histologic subtype with oncotype Dx recurrence score; retrospective review of 863 breast cancer oncotype Dx results
    Kamaljeet Singh
    Xin He
    Elizabeth T. Kalife
    Shahrzad Ehdaivand
    Yihong Wang
    C. James Sung
    Breast Cancer Research and Treatment, 2018, 168 : 29 - 34
  • [50] Cost impact of oncotype Dx® breast cancer assay use in a fully integrated healthcare delivery system
    Carlson, J. J.
    Watanabe, J.
    Boudreau, D.
    CANCER RESEARCH, 2013, 73
12345